Cancer Research · 2015 · 174 citations · 35 references
MedicineImmunologyOncologyCancer ImmunologyMetastasisTumor ImmunologyB Cell RegulationCancer Cell SignalingCancer ImmunotherapyCancer ProgressionMyeloid-derived Suppressor CellsT Cell Responses To TumorsGranulocytic Myeloid-derived Suppressor CellsMetastasis SuppressionMurine ModelsMyeloid-derived Suppressor Cell ExpansionMyeloid-derived Suppressor Cell FunctionMyeloid-derived Suppressor Cell ImmunosuppressionMyeloid-derived Suppressor Cell-mediated SuppressionRegulatory B Cell Function
Myeloid-derived suppressive cells (MDSC) have been reported to promote metastasis, but the loss of cancer-induced B cells/B regulatory cells (tBreg) can block metastasis despite MDSC expansion in cancer. Here, using multiple murine tumor models and human MDSC, we show that MDSC populations that expand in cancer have only partially primed regulatory function and limited prometastatic activity unless they are fully educated by tBregs. Cancer-induced tBregs directly activate the regulatory function of both the monocyte and granulocyte subpopulations of MDSC, relying, in part, on TgfβR1/TgfβR2 signaling. MDSC fully educated in this manner exhibit an increased production of reactive oxygen species and NO and more efficiently suppress CD4(+) and CD8(+) T cells, thereby promoting tumor growth and metastasis. Thus, loss of tBregs or TgfβR deficiency in MDSC is sufficient to disable their suppressive function and to block metastasis. Overall, our data indicate that cancer-induced B cells/B regulatory cells are important regulators of the immunosuppressive and prometastatic functions of MDSC.
35
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Je‐In Youn, Srinivas Nagaraj, Michelle Collazo et al. · The Journal of Immunology · 2008 · 1.6K citations · Full text
Life Sciences, Immunology, Oncology +16